Biological process | Gene symbol | Accession no | Gene description | Fold change |
---|---|---|---|---|
Innate immune response | MALT1 | XM_413722 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | +2.847583 |
CLU | NM_204900 | clusterin | +9.196763 | |
DMBT1 | CR353989 | deleted in malignant brain tumors 1 | +2.036204 | |
DUSP4 | NM_204838 | dual specificity phosphatase 4 | +19.50851 | |
DUSP6 | NM_204354 | dual specificity phosphatase 6 | +2.1367393 | |
DUSP10 | NM_001031044 | dual specificity phosphatase 10 | +2.5124102 | |
LY96 | BX931181 | lymphocyte antigen 96 | +4.2568717 | |
SAMHD1 | NM_001030845 | SAM domain and HD domain 1 | +5.7296877 | |
ERAP1 | AJ851612 | endoplasmic reticulum aminopeptidase 1 | +5.731377 | |
HMGB1 | NM_204902 | high mobility group box 1 | +3.24355 | |
TMEM173 | CR354327 | transmembrane protein 173 | +9.81937 | |
CFI | XM_426329 | complement factor I | +5.3699164 | |
IL1R1 | NM_205485 | interleukin 1 receptor, type I | +2.814695 | |
IRAK2 | NM_001030605 | interleukin-1 receptor-associated kinase 2 | +2.1085246 | |
IRF7 | NM_205372 | interferon regulatory factor 7 | +4.334887 | |
JUN | NM_001031289 | jun proto-oncogene | +3.481312 | |
MAP3K14 | NM_001030927 | mitogen-activated protein kinase kinasekinase 14 | +2.0599 | |
MYD88 | NM_001030962 | myeloid differentiation primary response gene (88) | +2.0273855 | |
NCF2 | CR391316 | neutrophil cytosolic factor 2 | +9.767744 | |
NFKB2 | NM_204413 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | +4.372285 | |
MASP1 | NM_213586 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | -5.984035 | |
PELI1 | NM_001012872 | pellino homolog 1 (Drosophila) | -2.6004448 | |
SIGIRR | NM_001199542 | single immunoglobulin and toll-interleukin 1 receptor (TIR) domain | -3.878401 | |
MRPS6 | NM_001031486 | mitochondrial ribosomal protein S6 | -7.8250012 | |
IFIH1 | NM_001193638 | interferon induced with helicase C domain 1 | +11.25022 | |
SRPK1 | XM_419265 | SFRS protein kinase 1 | +2.4798062 | |
TLR4 | NM_001030693 | toll-like receptor 4 | +2.019901 | |
TLR5 | CR353090 | toll-like receptor 5 | -2.4051092 | |
C1R | XM_416518 | complement component 1, r subcomponent | +13.635473 | |
C1S | NM_001030777 | complement component 1, s subcomponent | +16.500757 | |
C3 | NM_205405 | complement component 3 | +25.31715 | |
C4BPA | NM_204664 | complement component 4 binding protein, alpha | -2.476029 | |
C8B | BX934795 | complement component 8, beta polypeptide | -2.8326783 | |
TRIM25 | XM_415653 | tripartite motif-containing 25 | +3.5009384 | |
COLEC12 | NM_001039599 | collectin sub-family member 12 | -11.011364 | |
ITCH | XM_417330 | itchy homolog E3 ubiquitin protein ligase (mouse) | +2.3843937 | |
MARCO | NM_204736 | macrophage receptor with collagenous structure | -3.0318317 | |
FADD | XM_421073 | Fas (TNFRSF6)-associated via death domain | -2.127713 | |
IL18R1 | NM_001145225 | interleukin 18 receptor 1 | +3.5603435 | |
VNN1 | NM_001039288 | vanin 1 | +30.900112 | |
IL1RL1 | NM_204275 | interleukin 1 receptor-like 1 | -9.989544 | |
Cytokine-mediated signaling pathway | ADAR | AM179858 | adenosine deaminase, RNA-specific | +2.2560015 |
USP18 | CR354286 | ubiquitin specific peptidase 18 | +14.18105 | |
EGR1 | CR389000 | early growth response 1 | +4.516151 | |
IRF8 | NM_205416 | interferon regulatory factor 8 | +4.638908 | |
IFI35 | BX934680 | interferon-induced protein 35 | +4.3734093 | |
IFNGR1 | NM_001130387 | interferon gamma receptor 1 | +2.4954834 | |
IL6 | NM_204628 | interleukin 6 (interferon, beta 2) | +75.02113 | |
IL13RA2 | NM_001048078 | interleukin 13 receptor, alpha 2 | +5.0171814 | |
IRF1 | NM_205415 | interferon regulatory factor 1 | +7.012157 | |
IRF7 | NM_205372 | interferon regulatory factor 7 | +4.334887 | |
LIFR | NM_204575 | leukemia inhibitory factor receptor alpha | +2.3569908 | |
MX1 | NM_204609 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | +48.569965 | |
NCAM1 | NM_001242604 | neural cell adhesion molecule 1 | -7.5168643 | |
IP6K2 | NM_001030596 | inositol hexakisphosphate kinase 2 | +2.4397569 | |
PML | XM_413690 | promyelocytic leukemia | +3.3186321 | |
ZC3H15 | NM_001006510 | zinc finger CCCH-type containing 15 | -2.916313 | |
B2M | NM_001001750 | beta-2-microglobulin | +6.515671 | |
PTPN1 | L20630 | protein tyrosine phosphatase, non-receptor type 1 | +3.4228158 | |
PTPN2 | NM_001199387 | protein tyrosine phosphatase, non-receptor type 2 | +2.9723573 | |
CX3CL1 | NM_001077232 | chemokine (C-X3-C motif) ligand 1 | +10.652483 | |
STAT1 | NM_001012914 | signal transducer and activator of transcription 1, 91Â kDa | +12.110944 | |
STAT3 | NM_001030931 | signal transducer and activator of transcription 3 (acute-phase response factor) | +3.900449 | |
VCAM1 | BX950651 | vascular cell adhesion molecule 1 | -2.8632648 | |
OASL | NM_205041 | 2′-5′-oligoadenylate synthetase-like | +101.55924 | |
SOCS1 | NM_001137648 | suppressor of cytokine signaling 1 | +15.976115 | |
SOCS3 | NM_204600 | suppressor of cytokine signaling 3 | +30.325502 | |
CD44 | NM_204860 | CD44 molecule (Indian blood group) | +5.446098 | |
CD74 | NM_001001613 | CD74 molecule, major histocompatibility complex, class II invariant chain | -7.0005507 | |
Inflammatory response | CDO1 | CR353781 | cysteine dioxygenase, type I | -6.4660363 |
CEBPB | NM_205253 | CCAAT/enhancer binding protein (C/EBP), beta | +3.5429432 | |
IL23R | XM_422533 | interleukin 23 receptor | +3.9536817 | |
EPHX2 | NM_001033645 | epoxide hydrolase 2, cytoplasmic | -2.0498822 | |
LY96 | BX931181 | lymphocyte antigen 96 | +4.2568717 | |
BLNK | NM_204908 | B-cell linker | +3.781344 | |
AOAH | XM_418835 | acyloxyacyl hydrolase (neutrophil) | +3.389245 | |
AOX1 | NM_001038692 | aldehyde oxidase 1 | -3.0358417 | |
IGFBP4 | NM_204353 | insulin-like growth factor binding protein 4 | -2.5591307 | |
IL6 | NM_204628 | interleukin 6 (interferon, beta 2) | +75.02113 | |
IRAK2 | NM_001030605 | interleukin-1 receptor-associated kinase 2 | +2.1085246 | |
KNG1 | XM_422766 | kininogen 1 | -2.1926415 | |
LIPA | AJ719682 | lipase A, lysosomal acid, cholesterol esterase (Wolman disease) | +3.7113423 | |
LY75 | NM_001037836 | lymphocyte antigen 75 | +3.9913418 | |
NGFB | M26810 | nerve growth factor, beta polypeptide | -2.035398 | |
NOX4 | NM_001101829 | NADPH oxidase 4 | -9.4226265 | |
F11R | NM_001083366 | F11 receptor | +4.464096 | |
GAL | NM_001159678 | galaninprepropeptide | +8.09671 | |
SERPINA1 | BX932103 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | -30.80776 | |
S100A9 | X61200 | S100 calcium binding protein A9 | +32.001503 | |
CCL4 | NM_001030360 | chemokine (C-C motif) ligand 4 | +10.783558 | |
CCL17 | XM_414018 | chemokine (C-C motif) ligand 17 | +4.898831 | |
CCL19 | BX929857 | chemokine (C-C motif) ligand 19 | +2.0884924 | |
CCL20 | NM_204438 | chemokine (C-C motif) ligand 20 | +4.089286 | |
BMP2 | NM_204358 | bone morphogenetic protein 2 | +3.6641774 | |
TLR5 | CR353090 | toll-like receptor 5 | -2.4051092 | |
TNFAIP6 | NM_001037837 | tumor necrosis factor, alpha-induced protein 6 | +51.35508 | |
C3 | NM_205405 | complement component 3 | +25.31715 | |
SCG2 | BX932277 | secretogranin II (chromogranin C) | +3.5667899 | |
ITCH | XM_417330 | itchy homolog E3 ubiquitin protein ligase (mouse) | +2.3843937 | |
VNN1 | NM_001039288 | vanin 1 | +30.900112 | |
NMI | BX950337 | N-myc (and STAT) interactor | +3.1200686 | |
CHST2 | XR_027120 | carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 | -2.5672126 | |
HDAC9 | CR354257 | histone deacetylase 9 | -6.544272 |